重症急性胰腺炎治疗及营养支持的研究进展

doi:10.3969/j.issn.1004-583X.2023.12.014

摘要/Abstract

摘要：

急性胰腺炎(AP),作为一种在全球范围内普遍发生的胰腺炎症疾病,大部分表现为轻度。然而,约20%可能发展为具有较高死亡风险的重度急性胰腺炎(SAP)。SAP的治疗过程复杂且多元,关键治疗策略包括迅速进行充分的液体复苏、提供恰当的营养支持和高效的疼痛控制,并严格监控抗生素使用。此外,微创外科技术和内窥镜逆行胰胆管造影(Endoscopic retrograde cholangio-Pancreatography,ERCP)同样是治疗中的关键。目前,SAP的治疗方法不断进步,早期的肠内营养支持正在逐步取代传统的“胰腺休息”模式,阿片类药物和硬膜外麻醉已成为新兴的镇痛选择,同时,对于预防性抗生素的使用策略也进行了调整。本文旨在探讨SAP治疗的最新动态及面临的挑战。

关键词: 胰腺炎, 治疗学, 进展, 并发症

中图分类号:

R576

翟华珍, 李凌翔, 林秋满, 赖颖瑜, 杨心怡, 邓敏. 重症急性胰腺炎治疗及营养支持的研究进展[J]. 临床荟萃, 2023, 38(12): 1135-1139.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2023.12.014

https://huicui.hebmu.edu.cn/CN/Y2023/V38/I12/1135

参考文献 37

[1]	Zerem E, Kurtcehajic A, Kunosi'c S, et al. Current trends in acute pancreatitis: Diagnostic and therapeutic challenges[J]. World J Gastroenterol, 2023, 29(18): 2747-2763. doi: 10.3748/wjg.v29.i18.2747 URL
[2]	Sundar V, Kumar KAS, Manickam V, et al. Current trends in pharmacological approaches for treatment and management of acute pancreatitis-a review[J]. J Pharm Pharmacol, 2020, 72(6):761-775. doi: 10.1111/jphp.13229 URL
[3]	杜奕奇, 陈其奎, 李宏宇, 等. 中国急性胰腺炎诊治指南(2019年, 沈阳)[J]. 临床肝胆病杂志, 2019, 35(12): 2706-2711.
[4]	Cao L, Chen Y, Liu S, et al. Early plasmapheresis among patients with hypertriglyceridemia-associated acute pancreatitis[J]. JAMA, 2023, 6(6): e2320802.
[5]	Szatmary P, Grammatikopoulos T, Cai W, et al. Acute pancreatitis: diagnosis and treatment[J]. Drugs, 2022, 82(12): 1251-1276. doi: 10.1007/s40265-022-01766-4 pmid: 36074322
[6]	Trikudanathan G, Wolbrink DRJ, Van Santvoort HC, et al. Current concepts in severe acute and necrotizing pancreatitis: An evidence-based approach[J]. Gastroenterology, 2019, 156(7): 1994-2007.e3. doi: S0016-5085(19)30378-6 pmid: 30776347
[7]	Hey-Hadavi J, Velisetty P, Mhatre S. Trends and recent developments in pharmacotherapy of acute pancreatitis[J]. Postgrad Med, 2023, 135(4): 334-344. doi: 10.1080/00325481.2022.2136390 URL
[8]	Strand K, Møller JH. Fluid treatment in acute pancreatitis: A careful balancing act[J]. Br J Surg, 2023, 110(8):880-882. doi: 10.1093/bjs/znad155 pmid: 37327077
[9]	Mao E. Intensive management of severe acute pancreatitis[J]. Ann Transl Med, 2019, 7(22): 687. doi: 10.21037/atm.2019.10.58 pmid: 31930088
[10]	Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: A review[J]. JAMA, 2021, 325(4): 382-390. doi: 10.1001/jama.2020.20317 pmid: 33496779
[11]	Gomes CA, Di Saverio S, Sartelli M, et al. Severe acute pancreatitis: Eight fundamental steps revised according to the 'PANCREAS' acronym[J]. Ann R Coll Surg Engl, 2020, 102(8):555-559. doi: 10.1308/rcsann.2020.0029 URL
[12]	Machicado JD, Papachristou GI. Intravenous fluid resuscitation in the management of acute pancreatitis[J]. Curr Opin Gastroenterol, 2020, 36(5): 409-416. doi: 10.1097/MOG.0000000000000659 URL
[13]	De Waele E, Malbrain M, Spapen HD. How to deal with severe acute pancreatitis in the critically ill[J]. Curr Opin Crit Care, 2019, 25(2):150-156. doi: 10.1097/MCC.0000000000000596 pmid: 30730344
[14]	Thomson A. Intravenous fluid therapy in acute pancreatitis: A critical review of the randomized trials[J]. ANZ J Surg, 2018, 88(7-8): 690-696. doi: 10.1111/ans.14320 pmid: 29164816
[15]	Malbrain M, Langer T, Annane D, et al. Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA)[J]. Ann Intensive Care, 2020, 10(1): 64. doi: 10.1186/s13613-020-00679-3 pmid: 32449147
[16]	Cai W, Liu F, Wen Y, et al. Pain Management in acute pancreatitis: A systematic review and meta-analysis of randomised controlled trials[J]. Front Med (Lausanne), 2021, 17(8): 782151.
[17]	Thavanesan N, White S, Lee S, et al. Analgesia in the Initial management of acute pancreatitis: A systematic review and meta-analysis of randomised controlled trials[J]. World J Surg, 2022, 46(4): 878-890. doi: 10.1007/s00268-021-06420-w pmid: 34994837
[18]	Schorn S, Ceyhan GO, Tieftrunk E, et al. Pain management in acute pancreatitis[J]. Pancreapedia, 2015, 15:1-13.
[19]	Jabaudon M, Belhadj-Tahar N, Rimmelé T, et al. Thoracic Epidural Analgesia and Mortality in Acute Pancreatitis: A Multicenter Propensity Analysis[J]. Crit Care Med, 2018, 46(3): e198-e205. doi: 10.1097/CCM.0000000000002874 URL
[20]	Jabaudon M, Genevrier A, Jaber S, et al. Thoracic epidural analgesia in intensive care unit patients with acute pancreatitis: The EPIPAN multicenter randomized controlled trial[J]. Crit Care, 2023, 27(1): 213. doi: 10.1186/s13054-023-04502-w
[21]	Tyagi A, Gupta YR, Das S, et al. Effect of segmental thoracic epidural block on pancreatitisinduced organ dysfunction: A preliminary study[J]. Indian J Crit Care Med, 2019, 23(2): 89-94. doi: 10.5005/jp-journals-10071-23123 URL
[22]	Al-Leswas D, Baxter N, Lim WB, et al. The safety and efficacy of epidural anaesthesia in acute pancreatitis: A systematic review and meta-analysis[J]. HPB (Oxford), 2023, 25(2): 162-171. doi: 10.1016/j.hpb.2022.12.004 URL
[23]	Hines OJ, Pandol SJ. Management of severe acute pancreatitis[J]. BMJ, 2019, 367: l6227.
[24]	Song J, Zhong Y, Lu X, et al. Enteral nutrition provided within 48 hours after admission in severe acute pancreatitis: A systematic review and meta-analysis[J]. Medicine (Baltimore), 2018, 97(34): e11871. doi: 10.1097/MD.0000000000011871 URL
[25]	Li W, Liu J, Zhao S, et al. Safety and efficacy of total parenteral nutrition versus total enteral nutrition for patients with severe acute pancreatitis: A meta-analysis[J]. J Int Med Res, 2018, 46(9): 3948-3958. doi: 10.1177/0300060518782070 pmid: 29962261
[26]	De Lucia SS, Candelli M, Polito G, et al. Nutrition in acute pancreatitis: From the old paradigm to the new evidence[J]. Nutrients, 2023, 15(8):1939. doi: 10.3390/nu15081939 URL
[27]	Crockett SD, Wani S, Gardner TB, et al. American gastroenterological association institute guideline on initial management of acute pancreatitis[J]. Gastroenterology, 2018, 154(4): 1096-1101. doi: S0016-5085(18)30076-3 pmid: 29409760
[28]	Vivian E, Cler L, Conwell D, et al. Acute pancreatitis task force on quality: Development of quality indicators for acute pancreatitis management[J]. Am J Gastroenterol, 2019, 114(8): 1322-1142. doi: 10.14309/ajg.0000000000000264 pmid: 31205135
[29]	Ketwaroo G, Sealock R J, Freedman S, et al. Quality of care indicators in patients with acute pancreatitis[J]. Dig Dis Sci, 2019, 64(9): 2514-2526. doi: 10.1007/s10620-019-05674-8
[30]	Qi D, Yu B, Huang J, et al. Meta-analysis of early enteral nutrition provided within 24 hours of admission on clinical outcomes in acute pancreatitis[J]. JPEN J Parenter Enteral Nutr, 2018, 42(7): 1139-1147. doi: 10.1002/jpen.1139 pmid: 29377204
[31]	Purschke B, Bolm L, Meyer MN, et al. Interventional strategies in infected necrotizing pancreatitis: Indications, timing, and outcomes[J]. World J Gastroenterol, 2022, 28(27): 3383-3397. doi: 10.3748/wjg.v28.i27.3383 URL
[32]	Gomes CA, Di Saverio S, Sartelli M, et al. Severe acute pancreatitis: Eight fundamental steps revised according to the 'PANCREAS' acronym[J]. Ann R Coll Surg Engl, 2020, 102(8): 555-559. doi: 10.1308/rcsann.2020.0029 URL
[33]	Arvanitakis M, Ockenga J, Bezmarevic M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis[J]. Clin Nutr, 2020, 39(3): 612-31. doi: S0261-5614(20)30009-1 pmid: 32008871
[34]	Singh RR, Mitchell W, David Y, et al. Pancreatic fungal infection in patients with necrotizing pancreatitis: A systematic review and meta-analysis[J]. J Clin Gastroenterol, 2021, 55(3): 218-226. doi: 10.1097/MCG.0000000000001467 pmid: 33252558
[35]	Leonard-Murali S, Lezotte J, Kalu R, et al. Necrotizing pancreatitis: A review for the acute care surgeon[J]. Am J Surg, 2021, 221(5): 927-934. doi: 10.1016/j.amjsurg.2020.08.027 pmid: 32878690
[36]	Mancilla AsC, Berger FZ. Intra-abdominal hypertension: a systemic complication of severe acute pancreatitis[J]. Medicina (Kaunas), 2022, 58(6):785.
[37]	Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis[J]. Pancreatology, 2013, 13(< W>4 Suppl 2):e1-e15. doi: 10.1016/j.pan.2013.07.063 URL

重症急性胰腺炎治疗及营养支持的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 37

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王红, 金润浩. 社区老年人自我忽视的研究进展[J]. 临床荟萃, 2024, 39(2): 164-167.
[2]	崔兰丹, 杨春燕. 脓毒症患者甲状腺激素的变化特点及研究进展[J]. 临床荟萃, 2024, 39(1): 70-74.
[3]	陈聪水, 李园, 陈淑芳. 重视儿童胆源性胰腺炎的中西医诊治(附1例分析)[J]. 临床荟萃, 2023, 38(8): 726-730.
[4]	马光宇, 罗慧娟, 王冬菊, 肖小敏. 黄芩苷治疗糖尿病及其并发症的研究进展[J]. 临床荟萃, 2023, 38(8): 757-762.
[5]	张会, 丁东瑞, 金天然. 新型冠状病毒SARS-CoV-2的相关研究——过去与未来[J]. 临床荟萃, 2023, 38(7): 638-646.
[6]	刘倩, 马士恒, 张旭. 流行性腮腺炎并发急性肾衰竭1例及文献复习[J]. 临床荟萃, 2023, 38(6): 541-543.
[7]	高福生, 张川, 展玉涛. 经内镜逆行性胰胆管造影术后并发症相关影响因素分析及防治进展[J]. 临床荟萃, 2023, 38(6): 550-553.
[8]	于雪华, 张宁, 吴婧, 孙惠, 赵云红, 刘改芳. 血清抵抗素、丙二醛、IL-6联合检测对急性胰腺炎严重程度的预测价值[J]. 临床荟萃, 2023, 38(5): 412-416.
[9]	陆知非, 王高卿, 高过. 肝门部胆管癌的非手术治疗进展[J]. 临床荟萃, 2023, 38(5): 473-476.
[10]	马明福, 魏志国, 何铁英. 急性胰腺炎并发胰腺假性囊肿危险因素的meta分析[J]. 临床荟萃, 2023, 38(4): 293-301.
[11]	王凤华, 魏茂提. 干式桑拿疗法治疗慢性心力衰竭的研究进展[J]. 临床荟萃, 2023, 38(4): 369-372.
[12]	廖坤锋, 姚依松, 杨金盘, 杨西宁, 李亚如, 周红颜, 梁飘. 2型糖尿病患者恐惧疾病进展的现状及影响因素[J]. 临床荟萃, 2023, 38(12): 1095-1100.
[13]	吴昊天, 范玉雯, 张晓岚. 《中国慢性胃炎诊治指南(2022年,上海)》解读[J]. 临床荟萃, 2023, 38(10): 926-930.
[14]	任道聪, 王宁, 孟庆顺. 中西医结合治疗重症急性胰腺炎[J]. 临床荟萃, 2023, 38(10): 931-934.
[15]	邢婷婷, 高俊茶. Presepsin在急性胰腺炎中的研究进展[J]. 临床荟萃, 2022, 37(8): 764-768.